News

Stay
informed

Dance classes with Tango Libre

7 May 2019

In collaboration with Parkinson Québec, the Tango Libre dance company is about to start a new session adapted for people affected by Parkinson’s disease.

Classes will be held every Sunday from noon to 1:00 pm, from May 5 at Tango Libre’s studio located at 1650 Marie-Anne Street in Montreal.

Enjoy a preferential rate for the 8 sessions!

For information and registration, please contact Tango Libre at 514-527-5197 or by email at info@tangolibre.qc.ca

Read more +

May Webinar: Research by Pr Louis-Eric Trudeau

6 May 2019

The causes and the mode of action of Parkinson’s disease are still little known which is why several researchers are working on this topic. Since this field is very technical and there is a lot of research out there, it can be difficult to navigate.

This webinar will allow participants to answer the question: What’s new in Parkinson’s research?

The goal of this webinar is to share the latest news in research and make it accessible to all. This is a good way to know what is happening all over the world, but also in Quebec where research is very active.

 

Presentation…

Read more +

Défi Vélo: Jean Coutu Group and ProDoc as official presenter for a second year of collaboration!

Parkinson Québec has the honor to announce its partnership with Jean Coutu Group and Pro Doc as official presenter, for a new year of collaboration for the Défi Vélo.

The event will be held for its 9th edition in the beautiful Laurentians on Saturday, August 24th.

A word from our honorary president

 

« It is with pride that I renewed my commitment to co-chair the Défi Vélo. I have been supporting Parkinson Quebec for many years, the cause is very close to my heart because my first mentor and friend has this disease. I saw how the disease changed the daily life…

Read more +

Saucier-van Berkom Symposium: your annual opportunity to meet the greatest Quebec researchers in the field.

2 May 2019

Want to learn more about promising therapeutic options for treating Parkinson’s disease? The Saucier-van Berkom Symposium is your annual opportunity to meet the greatest Quebec researchers in the field.

This year, you will meet Martin Lévesque, Ph.D., professor in the Department of Psychiatry and Neuroscience at Laval University. He will present his most recent work on the mechanism of development of Parkinson’s disease. He will also explain how these discoveries can lead to drugs that can protect dopaminergic neurons or even replace those already lost.

** Conference only offered in French. 

 

Before the presentation, you can take part in a cocktail party.

 

WEDNESDAY…

Read more +

Sinemet © expected drug shortage and discontinued sale of Sinemet CR ©

10 April 2019

Levodopa is the drug of choice for the treatment of Parkinson’s disease. Since 2017, the commercial forms of this molecule, Sinemet © and Sinemet CR ©, are on average, unavailable nearly 20% of the time.

To explain this repeated shortage, the Merck laboratory, which markets these drugs, mainly invokes problems of supply in the drug manufacturing chain and delays in delivery.

On April 4, 2019, the Merck Lab announced that the production of the drug Sinemet CR © was discontinued and that this product would no longer be available in Canada or the United States.

The regular formulation of Sinemet ©, which…

Read more +

Visitez notre >> Centre info Parkinson